Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
17.55 USD | -1.07% | -7.00% | +191.04% |
Financials (USD)
Sales 2024 * | 2.14M | Sales 2025 * | - | Capitalization | 690M |
---|---|---|---|---|---|
Net income 2024 * | -65M | Net income 2025 * | -91M | EV / Sales 2024 * | 197 x |
Net cash position 2024 * | 267M | Net cash position 2025 * | 320M | EV / Sales 2025 * | - |
P/E ratio 2024 * |
-9.42
x | P/E ratio 2025 * |
-7.68
x | Employees | 50 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 85.5% |
Latest transcript on Longboard Pharmaceuticals, Inc.
1 day | -1.07% | ||
1 week | -7.00% | ||
Current month | -7.00% | ||
1 month | -20.39% | ||
3 months | -14.14% | ||
6 months | +276.61% | ||
Current year | +191.04% |
Managers | Title | Age | Since |
---|---|---|---|
Kevin Lind
CEO | Chief Executive Officer | 47 | 20-01-02 |
Brandi Roberts
DFI | Director of Finance/CFO | 50 | 20-12-31 |
Chief Tech/Sci/R&D Officer | - | - |
Members of the board | Title | Age | Since |
---|---|---|---|
Paul Sekhri
CHM | Chairman | 66 | 20-11-30 |
Director/Board Member | 68 | 20-11-30 | |
Vincent Aurentz
BRD | Director/Board Member | 56 | 20-01-31 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
0.41% | 4 M€ | -5.15% | - | |
0.00% | 32 M€ | +4.30% | - |
Date | Price | Change | Volume |
---|---|---|---|
24-06-07 | 17.55 | -1.07% | 181,900 |
24-06-06 | 17.74 | -3.48% | 179,822 |
24-06-05 | 18.38 | +1.72% | 184,079 |
24-06-04 | 18.07 | -4.54% | 201,599 |
24-06-03 | 18.93 | +0.32% | 262,585 |
Delayed Quote Nasdaq, June 07, 2024 at 04:00 pm EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+191.04% | 690M | |
+18.72% | 125B | |
+14.19% | 108B | |
-4.93% | 24.57B | |
+3.23% | 22.82B | |
-10.44% | 18.19B | |
-41.74% | 16.54B | |
-13.31% | 16.5B | |
+2.44% | 13.39B | |
+27.89% | 11.1B |
- Stock Market
- Equities
- LBPH Stock